Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Emerging Therapy
Advisory
Advocacy
Allergen Strategies
Allergence
Allergy-Friendly Products
Appeal
Correction
Coupons, Giveaways & Deals
Editorial
Emerging Technology
Emerging Therapy
Food Allergy Advocacy
Food Allergy Therapy
Food Allergy Treatment/Therapy
Legislation
Manufacturer Partnership
Media Coverage
New Product Announcements
News Coverage
Newsletter Archive
Parenting Strategies
Press Releases
Product Labeling
Product Previews
Product Safety
push
Resource Highlight
Safe Snack Guide
School Tools
Site
Social Media
Sponsored
Study
You be the Judge
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Emerging Therapy
FDA Approves First Treatment for Eosinophilic Esophagitis (EoE), a Chronic Immune...
News Wire ~ 3rd Party Press Release
-
2022/05/23
Emerging Therapy
Prota Therapeutics Achieves 51% Peanut Allergy Remission Rate in Kids with...
News Wire ~ 3rd Party Press Release
-
2022/05/16
Emerging Therapy
FDA Accepts Dupixent® (dupilumab) for Priority Review in Patients Aged 12...
News Wire ~ 3rd Party Press Release
-
2022/04/12
Emerging Therapy
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Dave Bloom
-
2022/04/06
Emerging Therapy
Stealth Mode Company Granted Patent for Sublingual Epinephrine Tablet
Dave Bloom
-
2022/03/25
Emerging Therapy
Sublingual Epinephrine for Anaphylaxis Receives Fast Track Designation from FDA
News Wire ~ 3rd Party Press Release
-
2022/03/18
Emerging Therapy
FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...
News Wire ~ 3rd Party Press Release
-
2022/03/04
Emerging Therapy
CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...
Dave Bloom
-
2022/03/02
Emerging Therapy
Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration
Dave Bloom
-
2022/03/01
Emerging Therapy
Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients
News Wire ~ 3rd Party Press Release
-
2022/02/28
1
2
3
...
19
Page 1 of 19